Genzyme Corp held its second investor meeting in two months to argue that its most promising experimental drug will capture five times the sales that Sanofi-Aventis has assumed in a hostile $18.5 ...
Genzyme Corp. GENZ and Bayer HealthCare Pharmaceuticals submitted a supplemental biologics license application to the Food and Drug Administration to expand the product label for Campath to include ...
The US Food and Drug Administration (FDA) on Thursday warned that serious cases of stroke and tears in the lining of arteries in the head and neck have occurred in patients with multiple sclerosis (MS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results